VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 330 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2017. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $9,673,000 | -25.2% | 607,618 | -2.3% | 2.68% | -24.8% |
| Q4 2017 | $12,928,000 | +43.4% | 622,146 | -1.1% | 3.57% | +40.8% |
| Q3 2017 | $9,013,000 | -17.8% | 629,003 | -0.8% | 2.54% | -16.1% |
| Q2 2017 | $10,964,000 | +54.9% | 633,787 | -1.2% | 3.02% | +56.8% |
| Q1 2017 | $7,078,000 | -9.2% | 641,738 | +19.5% | 1.93% | -9.1% |
| Q4 2016 | $7,795,000 | -51.1% | 536,894 | -17.4% | 2.12% | -50.0% |
| Q3 2016 | $15,956,000 | +13.3% | 649,959 | +13.4% | 4.24% | +17.3% |
| Q2 2016 | $14,086,000 | +103.2% | 573,321 | +117.5% | 3.62% | +115.4% |
| Q1 2016 | $6,933,000 | -2.4% | 263,641 | +277.3% | 1.68% | +4.3% |
| Q4 2015 | $7,102,000 | – | 69,874 | – | 1.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |